Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025

Avacta secures FDA clearance for second pre|CISION oncology programme

Guardant Health and Merck enter multi-year oncology diagnostics collaboration

Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis

EMA validates Daiichi Sankyo's ENHERTU plus pertuzumab application for first-line HER2 positive metastatic breast cancer

Immunovia gains California approval for PancreaSure and begins commercial rollout

Atossa Therapeutics' (Z)-endoxifen receives US FDA Orphan Drug Designation to treat Duchenne muscular dystrophy

Profusa launches Lumee tissue oxygen system for CRO market

OncoHost receives BIG Innovation Award in Health category

Hoth Therapeutics achieves European regulatory milestone for HT-001

Zydus Lifesciences acquires Agenus Inc's biologics manufacturing facilities, launches Zylidac Bio LLC in US

AVEO Oncology reports first patient dosed in front-line AML combination study of ficlatuzumab

GenomOncology and OHSU Knight Diagnostics Lab partner to enhance clinical trial matching for cancer patients

Rakuten Medical signs manufacturing agreement with LOTTE Biologics

Curasight reports preliminary data from Phase 1 trial in patients with high-grade gliomas